Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) — Financial Flexibility Index
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥43.41 Million (operating CF CN¥8.57 Million minus capex CN¥34.84 Million) represents 0% of total liabilities (CN¥513.25 Million). Also explore net asset momentum of Zhejiang Shapuaisi Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Shapuaisi Pharmaceutical Co Ltd Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Zhejiang Shapuaisi Pharmaceutical Co Ltd across 17 annual periods. Check Zhejiang Shapuaisi Pharmaceutical Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Year-by-year free cash flow to debt coverage for Zhejiang Shapuaisi Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Shapuaisi Pharmaceutical Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥153.78 Million | CN¥25.67 Million | CN¥516.59 Million | ▼ -49.8% |
| 2023 | 0.59x | CN¥261.29 Million | CN¥41.49 Million | CN¥440.92 Million | ▼ -46.0% |
| 2022 | 1.10x | CN¥264.41 Million | CN¥115.72 Million | CN¥240.99 Million | ▲ +0.5% |
| 2021 | 1.09x | CN¥254.23 Million | CN¥100.78 Million | CN¥232.89 Million | ▲ +553.5% |
| 2020 | 0.17x | CN¥61.27 Million | CN¥44.09 Million | CN¥366.78 Million | ▼ -79.0% |
| 2019 | 0.80x | CN¥79.80 Million | CN¥59.47 Million | CN¥100.28 Million | ▼ -16.1% |
| 2018 | 0.95x | CN¥158.75 Million | CN¥100.37 Million | CN¥167.41 Million | ▲ +26.1% |
| 2017 | 0.75x | CN¥159.57 Million | CN¥45.57 Million | CN¥212.13 Million | ▼ -44.2% |
| 2016 | 1.35x | CN¥334.27 Million | CN¥294.33 Million | CN¥247.88 Million | ▲ +143.6% |
| 2015 | 0.55x | CN¥212.21 Million | CN¥114.27 Million | CN¥383.37 Million | ▼ -75.8% |
| 2014 | 2.29x | CN¥250.52 Million | CN¥147.99 Million | CN¥109.44 Million | ▲ +194.9% |
| 2013 | 0.78x | CN¥189.59 Million | CN¥117.86 Million | CN¥244.26 Million | ▲ +35.1% |
| 2012 | 0.57x | CN¥139.18 Million | CN¥67.27 Million | CN¥242.33 Million | ▲ +61.0% |
| 2011 | 0.36x | CN¥44.74 Million | CN¥15.14 Million | CN¥125.43 Million | ▼ -1.9% |
| 2010 | 0.36x | CN¥25.62 Million | CN¥17.57 Million | CN¥70.45 Million | ▼ -24.9% |
| 2009 | 0.48x | CN¥37.36 Million | CN¥28.87 Million | CN¥77.15 Million | ▲ +38.5% |
| 2008 | 0.35x | CN¥24.21 Million | CN¥11.20 Million | CN¥69.24 Million | — |